Skip to main content
. 2020 Sep 10;10(9):1809. doi: 10.3390/nano10091809

Figure 3.

Figure 3

(A) Knockdown efficacies of various tyrosine-modified PPI- or PEI-based siRNA complexes targeting EGFP in PC3-EGFP/Luc cells (left). EGFP levels were determined by flow cytometry (see right panel and Figure S2C for original data). (B) Reduction of GAPDH mRNA levels in PC3 cells.